Not applicableStudy completedNCT01063140What this trial is testingRabies Immune Plasma Booster StudyWho this might be right forRabies CSL Behring 491
Large-scale testing (Phase 3)Study completedNCT01622062What this trial is testingImmunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis RegimenWho this might be right forRabies Sanofi Pasteur, a Sanofi Company 600
Testing effectiveness (Phase 2)Study completedNCT00656097What this trial is testingPhase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult SubjectsWho this might be right forRabies Crucell Holland BV 140
Testing effectiveness (Phase 2)Study completedNCT01228383What this trial is testingRabies Virus Neutralizing Activity and Safety of CL184, a Monoclonal Antibody Cocktail, in Simulated Rabies Post-Exposure Prophylaxis in Healthy AdultsWho this might be right forRabies Crucell Holland BV 240
Large-scale testing (Phase 3)Not Yet RecruitingNCT07055295What this trial is testingImmunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis RegimenWho this might be right forRabies Sinovac Biotech Co., Ltd 390
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07055880What this trial is testingImmunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)Who this might be right forRabies Sinovac Biotech Co., Ltd 120
Large-scale testing (Phase 3)Study completedNCT02491541What this trial is testingClinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese SubjectsWho this might be right forRabies Jiangsu Province Centers for Disease Control and Prevention 1,200
Very early researchUnknownNCT05832073What this trial is testingSafety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1Who this might be right forRabies Virus Infection Changchun BCHT Biotechnology Co. 152
Large-scale testing (Phase 3)Study completedNCT04127786What this trial is testingStudy of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines, Given in a Pre-exposure Regimen to Children and Adults and as Single Booster Dose to a Subset of AdultsWho this might be right forRabiesHealthy Volunteers Sanofi Pasteur, a Sanofi Company 1,708
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07168018What this trial is testingSafety and Immunogenicity of Coadministration of the Candidate Rabies Vaccine ChAdOx2 RabG and Licensed VaccineWho this might be right forRabies University of Oxford 40
Not applicableUnknownNCT03228069What this trial is testingImmune Responses and Immunological Tolerance After Rabies Booster Vaccination in HIV-infected AdultsWho this might be right forRabies Queen Saovabha Memorial Institute 40
Testing effectiveness (Phase 2)Study completedNCT02559921What this trial is testingSafety and Immunogenicity Study of Recombinant Human Rabies Immunoglobin (rhRIG) in Combination With Rabies Vaccine for Human Use With Human Rabies Immune Globulin (HRIG) in Combination With Rabies Vaccine for Human Use in Healthy Adult Subjects.Who this might be right forRabies Beijing Chaoyang District Centre for Disease Control and Prevention 300
Large-scale testing (Phase 3)Not Yet RecruitingNCT07455318What this trial is testingBoostability Assessment of Three Rabies Pre-Exposure Regimens in Healthy Volunteers 5 Years Following Priming.Who this might be right forRabies (Healthy Volunteers) Institute of Tropical Medicine, Belgium 561
Early research (Phase 1)Study completedNCT07342257What this trial is testingSYN023 With Rabies Vaccine in Healthy Pediatric SubjectsWho this might be right forRabies Post-exposure Prophylaxis Synermore Biologics (Suzhou) Co., Ltd. 108
Post-approval studies (Phase 4)Study completedNCT01137045What this trial is testingImmunogenicity and Safety Study of A New Chromatographically Purified Vero Cell Rabies Vaccine With ID Regimen and ERIGWho this might be right forRabies Queen Saovabha Memorial Institute 210
Early research (Phase 1)Study completedNCT00000884What this trial is testingPhase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult VolunteersWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 84
Large-scale testing (Phase 3)Active Not RecruitingNCT07275645What this trial is testingA Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10 to 60 YearsWho this might be right forRabies Ab&B Bio-tech Co., Ltd.JS 3,000
Not applicableActive Not RecruitingNCT07624461What this trial is testingReal-World Effectiveness of Zamerovimab and Mazorelvimab and Vaccine for Rabies Grade III Exposure in NanyangWho this might be right forRabies Post-exposure ProphylaxisRabies Synermore Biologics (Suzhou) Co., Ltd. 80
Early research (Phase 1)Study completedNCT06546709What this trial is testingDMID 23-0015; Lassa Fever CVD 1000Who this might be right forLassa Fever Wilbur Chen, MD, MS 54
Not applicableEnded earlyNCT01067079What this trial is testingSingle Center, Open Label, Follow up Study in Subjects Who Previously Received Rabies Vaccine as Simulated Post-Exposure RegimenWho this might be right forRabies Novartis Vaccines 200